STOCK TITAN

Kura Oncology officer proposes $108K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Kura Oncology, Inc. (KURA) reports that Brian Powl, an officer, filed a notice for the proposed sale of 15,254 common shares on approximately November 17, 2026, with an aggregate market value of $108,150.86. The shares were acquired from the issuer as restricted stock units on November 13, 2026. The notice lists May 22, 2026 as the plan adoption or instruction date for reliance on Rule 10b5-1.

Proposed sale 15,254 common shares Approximate sale date: November 17, 2026
Aggregate market value $108,150.86 Proposed sale of 15,254 common shares
Restricted Stock Units financial
"The shares were acquired as Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Rule 10b5-1 regulatory
"plan adoption or instruction date for reliance on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What prior KURA sales did Brian Powl report in the notice?

The prior-sales table lists 15,430 shares for gross proceeds of $165,852.44 on September 29; 8,000 shares for $84,497.60 on September 28; 9,020 shares for $94,685.65 on September 27; and 4,345 shares for $51,663.26 on August 21, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading